Ciplar Plus 5 Tablet: Uses, Side Effects, Dosage

Information about Ciplar Plus 5 Tablet

Ciplar Plus 5 Tablet is manufactured by Cipla Ltd. Ciplar Plus 5 Tablet is a combination of two medicines (Propranolol + Flunarizine). It is used for the prevention of migraine.

Ciplar Plus 5 Tablet Composition

  • Propranolol 40mg
  • Flunarizine 5mg

Ciplar Plus 5 Tablet Uses

Ciplar Plus 5 Tablet is used in the prevention and treatment of these diseases –

  • Prevention of migraine
  • Hypertension
  • Angina pectoris

Ciplar Plus 5 Tablet Dosage

The dosage is prescribed by the doctor based on your age, medical history, and current condition.

Take 1 tablet once a day or as directed by the doctor. Swallow it whole. Do not chew, crush or break it. Ciplar Plus 5 Tablet can be taken before or after a meal.

Ciplar Plus 5 Tablet Side effects

If your symptoms do not improve after taking it. Or if your condition worsens, consult your doctor immediately.

Common side effects are as follows-

  • Weight gain
  • Slow heart rate
  • Tiredness
  • Depression
  • Lethargy
  • Unusual dreams
  • Cold extremities

Apart from the above-mentioned side effects, there may be other side effects as well. If you notice any unusual symptoms while using the medicine, contact the doctor immediately.


Precautions-

Use its dosage as per the instructions given by the doctor.

Do not exceed the recommended dose.

Read the label carefully before use

Keep away from sunlight, in a cool and dry place.

Keep the medicine away from children and pets.

Betacap 10 Tablet: Uses, Side Effects, dosage

Betacap Plus 5 Tablet: Uses, Side Effects, dosage

Disclaimer: All the information and articles available on the newmaacare.com site are for educational purposes only. The information given here is to the best of our knowledge and experience. Do not use the information given here without expert advice. A qualified doctor should always be consulted for doctor tests and treatment.

Leave a Comment

Your email address will not be published. Required fields are marked *